![]() |
市場調查報告書
商品編碼
1863644
全球超音波設備市場:按技術、顯示類型、便攜性、應用、最終用戶和地區劃分-市場規模、產業趨勢、機會分析和預測(2025-2033 年)Global Ultrasound Devices Market: By technology, Display Type, Portability, Application, End Users, Region - Market Size, Industry Dynamics, Opportunity Analysis and Forecast for 2025-2033 |
||||||
超音波設備市場目前正經歷著以穩定成長和技術創新為特徵的轉型期。 2024 年,該市場規模約為 93.5 億美元,預計到 2033 年將顯著增長至約 141.8 億美元。這一增長反映了 2025 年至 2033 年預測期內 4.74% 的複合年增長率 (CAGR),凸顯了各個醫療領域對超音波技術日益增長的需求。
推動超音波設備市場發展的幾個關鍵趨勢正在發揮作用。其中最具影響力的發展之一是將人工智慧 (AI) 整合到超音波系統中。人工智慧可以增強影像分析能力、自動測量,並幫助臨床醫生更快、更準確地做出診斷,從而改善患者預後並提高工作流程效率。與人工智慧同步發展,便攜式床邊超音波(POCUS)設備的普及率也顯著提高。
目前,超音波市場正經歷策略性重組,這主要得益於與領先技術公司建立新的合作夥伴關係,以及主要參與者之間日益增強的垂直整合。隨著越來越多的公司尋求透過先進技術和營運效率來獲得競爭優勢,這些變化正在重塑競爭格局。一個值得關注的例子是,Sonomind 在 2025 年 10 月完成了 300 萬歐元(約 353 萬美元)的融資,用於進一步開發其神經調控超音波設備。這筆資金包括來自 Critical Path Ventures 的 200 萬歐元(約 235 萬美元)種子輪融資,以及透過法國政府 "法國 2030" 計畫獲得的 100 萬歐元額外投資。
為了因應這些不斷變化的市場動態,超音波產業的中小型企業正在採用 API 優先策略,以保持競爭力並保持市場地位。透過專注於開發能夠與其他醫療技術無縫整合的應用程式介面 (API),我們旨在提供靈活、可互通的解決方案,使其能夠順利融入現有的臨床工作流程。例如,Sonio 於 2025 年 8 月在美國發布了一條專為孕產婦護理設計的新型超音波產品線。這些產品強調與醫療服務提供者現有技術體系的便利集成,旨在提高診斷準確性和營運效率。
核心成長驅動因子
全球慢性病(尤其是心血管疾病、癌症和肝病)的日益增多,推動了對超音波等精準、即時診斷工具的需求成長。這些慢性病在全球造成了沉重且不斷增長的健康負擔,而早期準確的檢測方法對於改善患者預後至關重要。根據世界衛生組織 (WHO) 發布的 "2024 年全球疾病負擔報告" ,光是心血管疾病 (CVD) 每年就導致約 2,050 萬人死亡,凸顯了製定有效診斷策略的緊迫性。 早期診斷這些疾病至關重要,及時介入可以顯著降低死亡率,並改善全球數百萬患者的生活品質。
新機會與趨勢
在後疫情時代,遠距醫療已穩固確立其作為醫療服務基礎的地位。無線超音波市場在克服地域限制和專家短缺方面發揮關鍵作用。遠端超音波技術已成為一種創新解決方案,使醫療服務提供者能夠在專家資源有限的偏遠和醫療資源匱乏地區提供診斷影像服務。根據2024年發表在 "美國醫學會雜誌" (JAMA)上的一項研究,美國約有68%的鄉村診所已在其產前護理計畫中實施了遠距超音波。這種廣泛應用主要得益於FDA核准的無線超音波設備的普及。
優化障礙
持續存在的技能差距對市場上超音波設備的有效利用構成重大威脅,可能會削弱其在臨床環境中的潛在益處。根據美國超音波心臟學會2024年的一項調查,約43%的基層醫療服務提供者表示,即使完成了基礎培訓,他們仍然缺乏操作高級超音波系統的信心。這種信心的缺乏反映了掌握日益複雜的超音波技術所面臨的更廣泛挑戰,這些技術需要的不僅僅是基礎知識才能發揮最佳效用。隨著超音波設備變得越來越複雜和多功能,現有技術與使用者熟練程度之間的差距越來越大,這可能會限制超音波成像的準確性和臨床價值。
The ultrasound devices market is currently experiencing a transformative phase characterized by steady growth and technological innovation. Valued at approximately US$ 9.35 billion in 2024, the market is projected to expand significantly, reaching an estimated US$ 14.18 billion by 2033. This growth reflects a compound annual growth rate (CAGR) of 4.74% over the forecast period from 2025 to 2033, highlighting the increasing demand for ultrasound technology across various healthcare sectors.
Several key trends are driving this evolution within the ultrasound devices market. One of the most impactful developments is the integration of artificial intelligence (AI) into ultrasound systems. AI enhances image analysis, automates measurements, and assists clinicians in making faster and more accurate diagnoses, thereby improving patient outcomes and workflow efficiency. Alongside AI, there is a notable surge in the adoption of portable point-of-care ultrasound (POCUS) devices.
The ultrasound devices market is currently undergoing significant strategic realignments, driven by new partnerships with major technology companies and increasing vertical integration among key players. These shifts are transforming the competitive landscape, as companies seek to leverage advanced technologies and streamline their operations to gain an edge. A notable example occurred in October 2025 when Sonomind secured a substantial investment of €3 million (approximately $3.53 million) aimed at advancing its Neuromodulation Ultrasound Device. This funding included €2 million ($2.35 million) in seed capital from Critical Path Ventures alongside an additional €1 million provided through the French government's France 2030 initiative.
In response to these evolving market dynamics, smaller players in the ultrasound device industry are adopting API-first strategies to remain competitive and relevant. By focusing on developing application programming interfaces (APIs) that facilitate seamless integration with other healthcare technologies, these companies aim to provide more flexible, interoperable solutions that fit smoothly into existing clinical workflows. For instance, in August 2025, Sonio introduced a new suite of ultrasound offerings specifically designed for maternal care in the United States. These products emphasize ease of integration with current technology stacks used by healthcare providers, aiming to enhance both diagnostic accuracy and operational efficiency.
Core Growth Drivers
The global rise in chronic diseases, especially cardiovascular disorders, cancers, and liver conditions, is fueling an increasing demand for accurate and real-time diagnostic tools such as ultrasound. These chronic illnesses represent a significant and growing health burden worldwide, necessitating early and precise detection methods to improve patient outcomes. The World Health Organization's 2024 Global Burden of Disease Report highlights that cardiovascular diseases (CVDs) alone are responsible for approximately 20.5 million deaths annually, underscoring the urgent need for effective diagnostic strategies. Early diagnosis of such conditions is critical, as timely intervention can substantially reduce mortality rates and improve quality of life for millions of patients globally.
Emerging Opportunity Trends
The post-pandemic era has firmly established telemedicine as a fundamental component of healthcare delivery, with the wireless ultrasound devices market playing a crucial role in addressing geographic and specialist shortages. Tele-ultrasound technology has emerged as a transformative solution, enabling healthcare providers to extend diagnostic imaging services to remote and underserved areas where access to specialists is limited. According to a 2024 study published in JAMA, approximately 68% of rural clinics in the United States have incorporated tele-ultrasound into prenatal care programs. The availability of FDA-approved wireless ultrasound devices largely drives this widespread adoption.
Barriers to Optimization
A persistent skills gap poses a significant threat to the effective utilization of ultrasound devices in the market, undermining their potential benefits in clinical practice. According to a 2024 survey conducted by the American Society of Echocardiography, nearly 43% of primary care providers reported lacking confidence in operating advanced ultrasound systems, even after completing basic training. This lack of confidence reflects broader challenges in mastering increasingly sophisticated ultrasound technologies, which require more than rudimentary knowledge for optimal use. As ultrasound devices become more complex and feature-rich, the gap between available technology and user proficiency widens, potentially limiting the accuracy and clinical value of ultrasound imaging.
By Technology, diagnostic ultrasound technology holds a commanding dominance in the ultrasound devices market, capturing an impressive 92.4% share. This overwhelming preference is largely due to its non-invasive nature, which ensures patient safety while delivering high-quality imaging. Unlike other diagnostic methods that may involve radiation or invasive procedures, ultrasound uses sound waves to visualize internal structures, making it an ideal choice for repeated use and monitoring without risk. This safety profile has made diagnostic ultrasound a cornerstone in medical imaging, widely trusted across various healthcare specialties.
By Display Type, color ultrasound devices dominate the ultrasound devices market, commanding an impressive 90.9% share, largely because of their superior diagnostic accuracy compared to traditional grayscale systems. The ability to visualize blood flow, tissue vascularity, and movement in real-time with vibrant color imaging provides clinicians with critical information that enhances diagnostic confidence and precision. This advanced visualization capability is particularly valuable in complex cases where subtle differences in tissue characteristics or blood flow patterns can influence clinical decisions and patient outcomes.
By Portability, cart-based ultrasound systems continue to dominate the market with a substantial 57.31% share, maintaining their status as essential equipment in emergency rooms (ER) and intensive care units (ICU). Their robust performance, large display screens, and advanced imaging capabilities make them the preferred choice for critical care environments where quick and accurate diagnostics are paramount. A notable example of innovation within this category is Philips' Lumify system integrated with Reacts(R) tele-guidance technology.
By Application, radiology holds a commanding 29.6% share of the ultrasound devices market, largely propelled by the growing adoption of elastography technology. Elastography, a non-invasive imaging technique that measures tissue stiffness, has revolutionized diagnostic capabilities within radiology by providing more precise assessments of various conditions. This advancement has contributed significantly to radiology's leadership position in the ultrasound market, offering clinicians enhanced tools to improve patient outcomes while reducing the need for invasive procedures.
By Technology
By Display Type
By Portability
By Application
By End User
By Region
Geography Breakdown